98%
921
2 minutes
20
Microglia are the resident macrophages of the central nervous system and contribute to maintaining brain's homeostasis. Current 2D "petri-dish" cell culturing platforms employed for microglia, are unrepresentative of the softness or topography of native brain tissue. This often contributes to changes in microglial morphology, exhibiting an amoeboid phenotype that considerably differs from the homeostatic ramified phenotype in healthy brain tissue. To overcome this problem, multi-scale engineered polymeric microenvironments are developed and tested for the first time with primary microglia derived from adult rhesus macaques. In particular, biomimetic 2.5D micro- and nano-pillar arrays (diameters = 0.29-1.06 µm), featuring low effective shear moduli (0.25-14.63 MPa), and 3D micro-cages (volume = 24 × 24 × 24 to 49 × 49 × 49 μm) with and without micro- and nano-pillar decorations (pillar diameters = 0.24-1 µm) were fabricated using two-photon polymerization (2PP). Compared to microglia cultured on flat substrates, cells growing on the pillar arrays exhibit an increased expression of the ramified phenotype and a higher number of primary branches per ramified cell. The interaction between the cells and the micro-pillar-decorated cages enables a more homogenous 3D cell colonization compared to the undecorated ones. The results pave the way for the development of improved primary microglia models to study these cells in both healthy and diseased conditions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376863 | PMC |
http://dx.doi.org/10.3389/fbioe.2022.926642 | DOI Listing |
Immunopharmacol Immunotoxicol
September 2025
Neuroscience Research Center, Suleyman Demirel University, Isparta, Türkiye.
Background: Microglia are brain resident cells that control neural network maintenance, damage healing, and brain development. Microglia undergo apoptosis, cytokine production, and reactive free radicals of oxygen (ROS) in response to lipopolysaccharide (LPS) stimulation. TRPM2 is activated by LPS-induced oxidative stress, but it is inhibited by carvacrol (CARV) and N-(p-amylcinnamoyl)anthranilic acid (ACA).
View Article and Find Full Text PDFJ Neurochem
September 2025
Toxicology Unit, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Polar metabolic profiling, as well as bioenergetic assays, were used to characterize microglial responses to lipopolysaccharide, which induces a pro-inflammatory state, and interleukin-4, which is associated with an anti-inflammatory phenotype. BV2 microglial cells and primary microglia were used for these investigations. Results revealed that lipopolysaccharide-treated microglia exhibited an increased aerobic glycolytic activity measured by extracellular flux analysis, accompanied by increased levels of endogenous itaconate, a metabolite produced by the IRG1 enzyme.
View Article and Find Full Text PDFFront Immunol
September 2025
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
In order to preserve homeostasis, macrophages-phagocytic innate immune cells-interact with different tissue types, modulating immunological responses and secreting a variety of cytokines. They are extensively dispersed throughout the body's tissues and organs. Based on their developmental origins, tissue-resident macrophages (TRMs) in humans can be classified into those of embryonic origin and those derived from bone marrow-derived monocytes (BMDMs); embryonically derived macrophages emerge during early development, possess self-renewal capacity, and persist into adulthood in specific tissues such as microglia in the brain and Kupffer cells in the liver, whereas BMDMs originate from hematopoietic stem cells in the bone marrow via monocytic differentiation, infiltrate tissues during inflammation or injury, and differentiate into macrophages that transiently reside in tissues but lack self-renewal capability, thus requiring continuous replenishment.
View Article and Find Full Text PDFEur J Neurosci
September 2025
Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system (CNS) and is most often clinically presented in a relapsing form. Within MS lesions, oligodendrocyte progenitor cells (OPCs) differentiate into mature myelinating oligodendrocytes and mediate repair. A further understanding of the molecular mechanisms responsible for OPC differentiation will undoubtedly influence the direction of future treatments in MS.
View Article and Find Full Text PDFJ Immunol
September 2025
Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Texas A&M School of Medicine, Bryan, TX, United States.
Mounting evidence supports a critical role for central nervous system (CNS) glial cells in neuroinflammation and neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's Disease (PD), Multiple Sclerosis (MS), as well as neurovascular ischemic stroke. Previously, we found that loss of the PD-associated gene leucine-rich repeat kinase 2 (Lrrk2) in macrophages, peripheral innate immune cells, induced mitochondrial stress and elevated basal expression of type I interferon (IFN) stimulated genes (ISGs) due to chronic mitochondrial DNA engagement with the cGAS/STING DNA sensing pathway. Here we report that loss of LRRK2 results in a paradoxical response in microglial cells, a CNS-specific macrophage population.
View Article and Find Full Text PDF